MRTF-A and STAT3 synergistically promote breast cancer cell migration

Cellular Signalling

Volumn 26, Issue 11, 2014, Pages 2370-2380

  Liao, Xing Hua ^a,b   Wang, Nan ^a   Liu, Long Yue ^a   Zheng, Li ^a   Xing, Wen Jing ^a   Zhao, Dong Wei ^a   Sun, Xue Guang ^a   Hu, Peng ^b   Dong, Jian ^b   Zhang, Tong Cun ^a,b  

^a TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Breast cancer cell migration; Cyr 61; MRTF A; Myl 9; STAT3

Indexed keywords

MESSENGER RNA; MYOCARDIN RELATED TRANSCRIPTION FACTOR A; STAT3 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CYR61 PROTEIN, HUMAN; CYSTEINE RICH PROTEIN 61; MKL1 PROTEIN, HUMAN; MYL9 PROTEIN, HUMAN; MYOSIN LIGHT CHAIN; STAT3 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL; CELL COUNT; CELL DIFFERENTIATION; CELL MIGRATION; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REPORTER GENE; UPREGULATION; BIOSYNTHESIS; BREAST TUMOR; CELL MOTION; DNA RESPONSIVE ELEMENT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CYSTEINE-RICH PROTEIN 61; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MYOSIN LIGHT CHAINS; NEOPLASM PROTEINS; RESPONSE ELEMENTS; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84920192599     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2014.07.023     Document Type: Article

References (44)

1. Mayer M., Hunis A., Oratz R., Glennon C., Spicer P., Caplan E., Fallowfield L.J. Commun. Oncol. 2010, 7:406-412.
2. Kirui J.K., Xie Y., Wolff D.W., Jiang H., Abel P.W., Tu Y. J. Pharmacol. Exp. Ther. 2010, 333:393-403.
3. Lauffenburger D.A., Horwitz A.F. Cell 1996, 9:359-369.
4. Nobes C.D., Hall A. Cell 1995, 7:53-62.
5. Raftopoulou M., Hall A. Dev. Biol. 2004, 1:23-32.
6. Yoshio T., Morita T., Tsujii M., Hayashi N., Sobue K. Carcinogenesis 2010, 31:1185-1193.
7. Medjkane S., Perez-Sanchez C., Gaggioli C., Sahai E., Treisman R. Nat. Cell Biol. 2009, 11:257-268.
8. Pipes G.C., Creemers E.E., Olson E.N. Genes Dev. 2006, 15:1545-1556.
9. Parmacek M.S. Circ. Res. 2010, 23:168-170.
10. Teng T.S., Lin B., Manser E., Ng D.C., Cao X. J. Cell Sci. 2009, 15:4150-4159.
11. O'Sullivan L.A., Liongue C., Lewis R.S., Stephenson S.E., Ward A.C. Mol. Immunol. 2007, 44:2497-2506.
12. Yu H., Jove R. Nat. Rev. Cancer 2004, 4:97-105.
13. Turkson J. Expert Opin. Ther. Targets 2004, 8:409-422.
14. Haura E.B., Turkson J., Jove R. Nat. Clin. Pract. Oncol. 2005, 2:315-324.
15. Sato T., Neilson L.M., Peck A.R., Liu C., Tran T.H., Witkiewicz A., Hyslop T., Nevalainen M.T., Sauter G., Rui H. Am J Cancer Res. 2011, 1:347-355.
16. Dien J., Amin H.M., Chiu N., Wong W., Frantz C., Chiu B., Mackey J.R., Lai R. Am. J. Pathol. 2006, 169:633-642.
17. Yau C.Y., Wheeler J.J., Sutton K.L., Hedley D.W. Cancer Res. 2005, 15:1497-1504.
18. Garcia R., Yu C.L., Hudnall A., Catlett R., Nelson K.L., Smithgall T., Fujita D.J., Ethier S.P., Jove R. Cell Growth Differ. 1997, 8:1267-1276.
19. Watson C.J., Miller W.R. Br. J. Cancer 1995, 71:840-844.
20. Bowman T., Broome M.A., Sinibaldi D., Wharton W., Pledger W.J., Sedivy J.M., Irby R., Yeatman T., Courtneidge S.A., Jove R. Proc. Natl. Acad. Sci. U. S. A. 2001, 19:7319-7324.
21. Bromberg J., Darnell J.E. Oncogene 2000, 15:2468-2473.
22. Kamran M.Z., Patil P., Gude R.P. Biomed. Res. Int. 2013, 2013:421821.
23. Chen H.F., Deng H.Y., Fan W.K. Sichuan Da Xue Xue Bao Yi Xue Ban 2008, 39:63-65. (83).
24. Raptis L., Arulanandam R., Geletu M., Turkson J. Exp. Cell Res. 2011, 1:1787-1795.
25. Azare J., Leslie K., Al-Ahmadie H., Gerald W., Weinreb P.H., Violette S.M., Bromberg J. Mol. Cell. Biol. 2007, 27:4444-4453.
26. Chen H.C. Methods Mol. Biol. 2005, 294:15-22.
27. Cheng G.Z., Zhang W.Z., Sun M., Wang Q., Coppola D., Mansour M., Xu L.M., Costanzo C., Cheng J.Q., Wang L.H. J. Biol. Chem. 2008, 23:14665-14673.
28. Liao X.H., Li Y.Q., Wang N., Zheng L., Xing W.J., Zhao D.W., Yan T.B., Wang Y., Liu L.Y., Sun X.G., Hu P., Zhou H., Zhang T.C. Cell Signal. 2014, 26:1335-1346.
29. Di Carlo E., Diodoro M.G., Boggio K., Modesti A., Modesti M., Nanni P., Forni G., Musiani P. Lab. Investig. 1999, 79:1261-1269.
30. Llewellyn B.D. Biotech. Histochem. 2009, 84:159-177.
31. Betapudi V., Licate L.S., Egelhoff T.T. Cancer Res. 2006, 1:4725-4733.
32. Wyckoff J.B., Pinner S.E., Gschmeissner S., Condeelis J.S., Sahai E. Curr. Biol. 2006, 8:1515-1523.
33. Harris L.G., Pannell L.K., Singh S., Samant R.S., Shevde L.A. Oncogene 2012, 12:3370-3380.
34. Sampath D., Winneker R.C., Zhang Z. Endocrinology 2001, 142:2540-2548.
35. Small E.M., Thatcher J.E., Sutherland L.B., Kinoshita H., Gerard R.D., Richardson J.A., Dimaio J.M., Sadek H., Kuwahara K., Olson E.N. Circ. Res. 2010, 23:294-304.
36. Zhang Y., Turkson J., Carter-Su C., Smithgall T., Levitzki A., Kraker A., Krolewski J.J., Medveczky P., Jove R. J. Biol. Chem. 2000, 11:24935-24944.
37. Rahaman S.O., Harbor P.C., Chernova O., Barnett G.H., Vogelbaum M.A., Haque S.J. Oncogene 2002, 5:8404-8413.
38. Wang G., Woods A., Sabari S., Pagnotta L., Stanton L.A., Beier F. J. Biol. Chem. 2004, 26:13205-13214.
39. Libson S., Lippman M. Int. Rev. Psychiatry 2014, 26:4-15.
40. Yamazaki D., Kurisu S., Takenawa T. Cancer Sci. 2005, 96:379-386.
41. Ridley A.J., Schwartz M.A., Burridge K., Firtel R.A., Ginsberg M.H., Borisy G., Parsons J.T., Horwitz A.R. Science 2003, 5:1704-1709.
42. Wong M., Kireeva M.L., Kolesnikova T.V., Lau L.F. Dev. Biol. 1997, 15:492-508.
43. Hanna M., Liu H., Amir J., Sun Y., Morris S.W., Siddiqui M.A., Lau L.F., Chaqour B. J. Biol. Chem. 2009, 21:23125-23136.
44. Bowman T., Garcia R., Turkson J., Jove R. Oncogene 2000, 15:2474-2488.